This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

  • CDC Flu Update: Second Wave of Influenza B Virus Activity Hits
    According to this week’s FluView report from the Centers for Disease Control and Prevention (CDC), flu activity continues to decrease in the United States. While flu activity has peaked nationally for this season, some parts of the country are still experiencing ...More
    3 weeks ago Posted in News
  • Device May Provide Rapid Diagnosis of Bacterial Infections
    A team of Massachusetts General Hospital (MGH) investigators has developed a device with the potential of shortening the time required to rapidly diagnose pathogens responsible for healthcare-associated infections from a couple of days to a matter of hours. The system ...More
    3 weeks ago Posted in News
  • Targeted Antibiotic is Easier on the Gut Microbiome
    A targeted antibiotic designed for treatment of staph infections caused fewer changes to the gut microbiome of mice than did common broad-spectrum antibiotics. St. Jude Children's Research Hospital scientists led the study, which provides the first evidence that a ...More
    3 weeks ago Posted in News
  • Investigational Malaria Vaccine Protects Healthy U.S. Adults for More Than One Year
    An experimental malaria vaccine protected a small number of healthy, malaria-naïve adults in the United States from infection for more than one year after immunization, according to results from a Phase 1 trial described in the May 9 issue of Nature Medicine. The ...More
    3 weeks ago Posted in News
  • When Beneficial Bacteria 'Knock' But No One is Home
    The community of beneficial bacteria that live in our intestines, known as the gut microbiome, are important for the development and function of the immune system. There has been growing evidence that certain probiotics--therapies that introduce beneficial bacteria into the ...More
    3 weeks ago Posted in News
  • Treating Hepatitis C: Pay Now or Pay More Later
    The price of curing hepatitis C in the long term is much cheaper than the ongoing expense of older therapies or delayed treatments, including liver transplants, according to a group of studies published this month in a special edition of the American Journal of Managed ...More
    3 weeks ago Posted in News
  • Pitt-Developed Drug Works Against Bacterial Biofilms and Respiratory Virus
    A potential drug therapy developed at the University of Pittsburgh Center for Vaccine Research (CVR) has proven effective against tough bacterial biofilms and a deadly respiratory virus simultaneously. The drug outperforms traditional therapies in the laboratory setting. ...More
    3 weeks ago Posted in News
  • Novel Role for Spleen B Cells in Inflammatory Response to Bacterial Toxins
    The inability to adequately respond to infection can cause a whole-body state of inflammation known as sepsis. This can eventually lead to systemic inflammatory response syndrome (SIRS), and even death. White blood cells known as B lymphocytes (B cells) produce antibodies ...More
    3 weeks ago Posted in News
  • Recommendations for Strengthening Global Health Security
    The announcement in April that the World Health Organization (WHO) had begun the process of electing its next director-general could mark renewed effort to strengthen the enforcement of the International Health Regulations (IHR). In the wake of the recent Ebola crisis, ...More
    3 weeks ago Posted in News
  • Yellow Fever Epidemic: A New Global Health Emergency?
    Evidence is mounting that the current outbreak of yellow fever is becoming the latest global health emergency, say two Georgetown University professors, who call on the World Health Organization (WHO) to convene an emergency committee under the International Health ...More
    3 weeks ago Posted in News